← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Vincere Biosciences, Inc.
Cambridge, MA
$1,250,709
Total funding
3
Grants
Funding over time
peak $470.5K · FY2020–24$500K$375K$250K$125K$0
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$1,250,709 · 3
By mechanism
R43$1,250,709 · 3
Investigators at Vincere Biosciences, Inc.
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's Disease$470,514
R43 · FY2023 · NS
Evaluation of USP30 small molecule inhibitors in models relevant to Cardiac Aging$299,497
R43 · FY2022 · AG
Discovery and Development of USP30 inhibitors as Disease-Modifying Therapy for Parkinson's disease.$251,987
R43 · FY2020 · NS
In vivo Evaluation of USP30 Inhibitors in Models Relevant to Parkinson's Disease$228,711
R43 · FY2024 · NS